Results 251 to 260 of about 2,363,330 (306)

Immunomodulatory functions of fungal melanins in respiratory infections. [PDF]

mBio
Basham KJ, Ward RA, Vyas JM, Nolling Jensen K.   +3 more
europepmc   +1 more source

High-Efficiency Particulate Air Filters to Prevent Winter Respiratory Infections in Care Homes: The AFRI-c Cluster Randomized Clinical Trial.

JAMA Intern Med
Hay AD, Brierley RCM, Turner N, Thorn JC, Rees S, Brown CE, Campbell-Smith L, Gidman EA, Henderson EJ, Mazza G, Morgan G, Ready D, Riddington C, Sprackman J, Taylor J, Welsh T, Kipping R.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Respiratory Infections

Clinics in Chest Medicine, 2023
Pneumonia is one of the most common reasons for health care utilization in the United States. It can be caused by many different pathogens, but rarely is it able to be identified in specific cases. This has led most racial disparities research to focus on community acquired pneumonia and microbes of public health concern such as influenza, tuberculosis,
Joshua F, Detelich, Jordan A, Kempker
openaire   +2 more sources

The respiratory microbiome and respiratory infections

Journal of Infection, 2017
Despite advances over the past ten years lower respiratory tract infections still comprise around a fifth of all deaths worldwide in children under five years of age with the majority in low- and middle-income countries. Known risk factors for severe respiratory infections and poor chronic respiratory health do not fully explain why some children ...
Stefan A, Unger, Debby, Bogaert
openaire   +2 more sources

Occupational Respiratory Infections

Clinics in Chest Medicine, 2020
Occupational respiratory infections can be caused by bacterial, viral, and fungal pathogens. Transmission in occupational settings can occur from other humans, animals, or the environment, and occur in various occupations and industries. In this article, we describe 4 occupationally acquired respiratory infections at the focus of NIOSH investigations ...
Marie A, de Perio, Miwako, Kobayashi, Jonathan M, Wortham   +2 more
openaire   +2 more sources

Probiotics in Respiratory Infections

2013
Probiotics are an established therapeutic or preventive intervention for gastrointestinal diseases and their efficacy is supported by several mechanisms, including the modulation of the immune response. However, there is evidence that the administration of probiotics may also be effective in the prevention or treatment of respiratory infections. Trials
BRUZZESE, EUGENIA, LO VECCHIO, ANDREA, RUBERTO, ELIANA   +2 more
openaire   +2 more sources

Nosocomial Respiratory Infections

Infection Control, 1983
AbstractNosocomial respiratory tract infections are major causes of excessive morbidity and mortality in US hospitals, affecting an estimated five to ten of every 1,000 patients. Patients with serious underlying diseases have an especially high risk of acquiring these infections, and that risk is magnified by exposure to respiratory therapy.
openaire   +2 more sources

Sleep and Respiratory Infections

Seminars in Respiratory and Critical Care Medicine
AbstractSleep disorders that involve circadian rhythm disruption and sleep-disordered breathing (SDB) such as obstructive sleep apnea (OSA) are closely linked to respiratory infections. SDB leads to a proinflammatory state due to intermittent hypoxia, sleep fragmentation, increased oxidative stress, and elevation of inflammatory mediators such as tumor
Ignacio, Boira, Eusebi, Chiner
openaire   +2 more sources

Ceftazidime for respiratory infections

Expert Opinion on Pharmacotherapy, 2012
Ceftazidime is a third-generation cephalosporin that has activity against Gram-negative bacilli, including Pseudomonas aeruginosa. The increasing prevalence of antimicrobial resistance and the limited number of antimicrobial agents in development have necessitated a review of the current status of treatments involving ceftazidime.This review focuses on
Sang-Ho, Choi, Younsuck, Koh
openaire   +2 more sources